// App-Quantinova.ai

1493 : Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Researchers

Presenter

  • Joachim Beck

Principal Investigators

  • Monika Brueggemann

  • Hubert Serve

  • Bernd M Spriewald

  • Michael Starck

  • Matthias Stelljes

  • Andreas Viardot

  • Knut Wendelin

  • Dieter Hoelzer

  • Thomas Burmeister

  • Eike C. Buss

  • Norbert Frickhofen

  • Andreas Huettmann

  • Anke Morgner

  • Albrecht Reichle

  • Ingo Schmidt-Wolf

  • Stefan Schwartz

Medical Centers

  • University Hospital of Erlangen, Dept. of Internal Medicine - Hematology/Oncology, Erlangen, Germany

  • Hematology and Oncology, University Regensburg, Regensburg, Germany

  • Department of Internal Medicine II, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany

  • Department of Medicine A / Hematology and Oncology, University of Muenster, Muenster, Germany

  • Klinik fur Innere Medizin III, Klinikum Chemnitz, Chemnitz, Germany

  • Dept. of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

  • University Hospital Bonn, Bonn, Germany

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Hematology / Oncology, HSK, Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany

  • Medical Department II, University Medical Center of Schleswig-Holstein Kiel, Kiel, Germany

  • Hematology, University Hospital, Essen, Germany

  • Hematology and Oncology, Charite Campus Benjamin Franklin, Berlin, Germany

  • Dept. of Medicine III, University Hospital, Mainz, Germany

  • Dept. of Medicine I, Klinikum Munchen-Schwabing, Munchen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • B-lymphocyte antigen CD20

  • White Blood Cell

Drug/Treatment

  • Cytarabine liposomal

  • Idarubicin Hydrochloride

  • Rituximab

  • Floctafenine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved